Arley Gómez-López

615 total citations
10 papers, 386 citations indexed

About

Arley Gómez-López is a scholar working on Infectious Diseases, Molecular Biology and Dermatology. According to data from OpenAlex, Arley Gómez-López has authored 10 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Molecular Biology and 2 papers in Dermatology. Recurrent topics in Arley Gómez-López's work include Antifungal resistance and susceptibility (2 papers), COVID-19 Clinical Research Studies (2 papers) and HIV/AIDS drug development and treatment (2 papers). Arley Gómez-López is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), COVID-19 Clinical Research Studies (2 papers) and HIV/AIDS drug development and treatment (2 papers). Arley Gómez-López collaborates with scholars based in Colombia, Belgium and Switzerland. Arley Gómez-López's co-authors include Anne–Mieke Vandamme, Andrea-Clemencia Pineda-Peña, Túlio de Oliveira, Pieter Libin, Koen Deforche, Ricardo Camacho, Ana Abecasis, Nuno R. Faria, Stijn Imbrechts and Adriana Rojas‐Villarraga and has published in prestigious journals such as BMC Microbiology, BMC Infectious Diseases and ACS Omega.

In The Last Decade

Arley Gómez-López

10 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arley Gómez-López Colombia 7 297 261 106 59 17 10 386
Zuoyi Bao China 13 442 1.5× 436 1.7× 147 1.4× 49 0.8× 22 1.3× 55 521
Iain Tatt United Kingdom 9 256 0.9× 272 1.0× 67 0.6× 42 0.7× 9 0.5× 14 425
Stijn Imbrechts Belgium 5 282 0.9× 307 1.2× 98 0.9× 41 0.7× 18 1.1× 6 348
Marcel Tongo Cameroon 9 205 0.7× 236 0.9× 79 0.7× 62 1.1× 29 1.7× 29 310
Aubin Nanfack Cameroon 16 411 1.4× 399 1.5× 164 1.5× 69 1.2× 15 0.9× 41 588
Daomin Zhuang China 11 342 1.2× 333 1.3× 107 1.0× 30 0.5× 16 0.9× 45 428
Djeneba Fofana France 14 309 1.0× 264 1.0× 111 1.0× 38 0.6× 8 0.5× 35 420
Gema Casado Spain 9 294 1.0× 344 1.3× 110 1.0× 22 0.4× 15 0.9× 12 361
Fred Kyeyune Uganda 11 275 0.9× 275 1.1× 47 0.4× 49 0.8× 6 0.4× 16 321
Junko Hattori Japan 12 251 0.8× 265 1.0× 124 1.2× 77 1.3× 23 1.4× 32 414

Countries citing papers authored by Arley Gómez-López

Since Specialization
Citations

This map shows the geographic impact of Arley Gómez-López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arley Gómez-López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arley Gómez-López more than expected).

Fields of papers citing papers by Arley Gómez-López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arley Gómez-López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arley Gómez-López. The network helps show where Arley Gómez-López may publish in the future.

Co-authorship network of co-authors of Arley Gómez-López

This figure shows the co-authorship network connecting the top 25 collaborators of Arley Gómez-López. A scholar is included among the top collaborators of Arley Gómez-López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arley Gómez-López. Arley Gómez-López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gómez-López, Arley, et al.. (2025). Virus Inactivation by Catalytic Air Converter Filters: The Role of Coating Methods. ACS Omega. 10(35). 40590–40600. 1 indexed citations
2.
Gómez-López, Arley, et al.. (2022). Application of nanotechnology in ophthalmology: Where are we?. 5(1). 66–66. 3 indexed citations
3.
Garavito, Édgar, et al.. (2021). Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients. Reumatología Clínica (English Edition). 17(7). 371–375. 9 indexed citations
5.
Garavito, Édgar, et al.. (2020). Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients. Reumatología Clínica. 17(7). 371–375. 36 indexed citations
6.
Fiori, Alessandro, Katrien Lagrou, Milcíades Ibáñez‐Pinilla, et al.. (2015). New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study. BMC Infectious Diseases. 15(1). 108–108. 6 indexed citations
7.
Fiori, Alessandro, Beatriz L. Gómez, Claudia Marcela Parra‐Giraldo, et al.. (2015). Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia. BMC Microbiology. 15(1). 199–199. 19 indexed citations
8.
Pineda-Peña, Andrea-Clemencia, Nuno R. Faria, Stijn Imbrechts, et al.. (2013). Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: Performance evaluation of the new REGA version 3 and seven other tools. Infection Genetics and Evolution. 19. 337–348. 285 indexed citations
9.
Pineda-Peña, Andrea-Clemencia, Otto Sussmann, Anne–Mieke Vandamme, et al.. (2013). HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?. PubMed. 14(4). 256–67. 12 indexed citations
10.
Gómez-López, Arley, et al.. (2012). Similar Biotherapeutic Products: Overview and Reflections. Immunotherapy. 4(12). 1841–1857. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026